Nevertheless, the consistent results observed across two independent computational frameworks enhance the reliability of our findings and further substantiate the central involvement of TIGIT+ CD8+ T cells in CRC pathophysiology. The gene discussed is TIGIT; the disease is colorectal carcinoma.